Childhood nephrotic syndrome in relapse is associated with down-regulation of monocyte CD14 expression and lipopolysaccharide-induced tumour necrosis factor-α production

Clinical and Experimental Immunology

Volumn 134, Issue 1, 2003, Pages 111-119

  Chen, S P ^a   Cheung, W ^a   Heng, C K ^a   Jordan, S C ^b   Yap, Hui Kim ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD14; Lipopolysaccharide; Monocyte; Nephrotic syndrome; TNF

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CELL STIMULATION; CHILD; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MALE; MONOCYTE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; REMISSION; RNA TRANSLATION; SEPSIS; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIGENS, CD14; CASE-CONTROL STUDIES; CELL MEMBRANE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; MONOCYTES; NEPHROTIC SYNDROME; RECURRENCE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141539414     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02252.x     Document Type: Article

References (45)

1. International Study of Kidney Disease in Children. Nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 1978; 13:159-65.
2. Wifert CM, Katz S. Etiology of bacterial sepsis in nephrotic children 1963-67. Pediatrics 1968; 42:840-3.
3. Krensky AM, Ingelfinger JR, Grupe WE. Peritonitis in childhood nephrotic syndrome. Am J Dis Child 1982; 136:732-6.
4. International Study of Kidney Disease in Children. Minimal change nephrotic syndrome: deaths during the first 5-15 years' observation. Pediatrics 1984; 73:497-501.
5. Asmar BI, Bashour BN, Fleischmann LE. Escherichia coli in children with idiopathic nephrotic syndrome. Clin Pediatr 1987; 26:592-4.
6. Gorensek MJ, Lebel MH, Nelson JD. Peritonitis in children with nephrotic syndrome. Pediatrics 1988; 81:849-56.
7. Feinstein EI, Chesney RW, Zelikovic I. Peritonitis in children with renal disease. Am J Nephrol 1988; 8:147-65.
8. Ilyas M, Roy S, IIIAbbasi S et al. Serious infections due to penicillin-resistant Streptococcus pneumoniae in two children with nephrotic syndrome. Pediatr Nephrol 1996; 10:639-41.
9. Tain YL, Lin GJ, Cher TW. Microbiological spectrum of septicemia and peritonitis in nephrotic children. Pediatr Nephrol 1999; 13:835-7.
10. Gianghacomo J, Cleary TG, Cole BR et al. Serum immunoglobulins in the nephrotic syndrome. N Engl J Med 1975; 293:8-12,.
11. 4) in nephrotic syndrome due to minimal change and other forms of glomerulonephritis, a clue for steroid therapy? Nephron 1987; 47:125-30.
12. Anderson DC, York TL, Rose G et al. Assessment of serum factor B, serum opsonins, granulocyte chemotaxis, and infection in nephrotic syndrome. J Infect Dis 1979; 140:1-10.
13. Schnaper HW, Aune TM. Steriod-sensitive mechanism of soluble immune response suppressor production in steroid-responsive nephrotic syndrome. J Clin Invest 1987; 79:257-64,.
14. Yap HK, Cheung W, Murugasu B et al. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999; 10:529-37.
15. McKenzie ANJ, Culpepper JA, de Waal Malefyt R et al. Interleukin 13, a T-cell derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993; 90:3735-9.
16. De Waal Malefyt R, Figdor CG, Huijbens R et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J Immunol 1993; 151:6370-81.
17. Defrance T, Carayon P, Billian G et al. Interleukin 13 is a B cell stimulating factor. J Exp Med 1994; 179:135-43.
18. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90:3730-4.
19. Zurawski G, De Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-26.
20. Cosentino G, Soprana E, Thienes CP et al. IL-13 down-regulates CD14 expression and TNF-α secretion in normal human monocytes. J Immunol 1995; 155:3145-51.
21. Haziot A, Chen S, Ferrero E et al. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988; 141:547-52.
22. Pugin J, Heumann D, Tomasz A et al. CD14 is a pattern recognition receptor. Immunity 1994; 1:509-16.
23. Wright SD, Ramos RA, Tobias PS et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-3.
24. Gupta D, Kirkland TN, Viriyakosol S et al. CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem 1996; 271:23310-6.
25. Netea MG, Kullberg BJ, Van Der Meer JWM. Lipopolysaccharide-induced production of tumour necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD14-dependent and CD14-independent pathways. Immunology 1998; 94:340-4.
26. Grunwald U, Fan XL, Jack RS et al. Monocytes can phagocytose gramnegative bacteria by a CD14-dependent mechanism. J Immunol 1996; 157:4119-25.
27. Picker LJ, Singh MK, Zdraveski Z et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86:1406-19.
28. Openshaw P, Murphy EE, Hosken NA et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995; 182:1357-67.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
30. Matsumoto K. Decreased production of interleukin-1 by monocytes from patients with lipoid nephrosis. Clin Nephrol 1989; 31:292-6.
31. Antal-Szalmás P. Evaluation of CD14 in host defense. Eur J Invest 2000; 30:167-79.
32. Pugin J, Schürer-Maly CC, Leturcq D et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90:2744-8.
33. Pugin J, Ulevitch RJ, Tobias PS. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J Exp Med 1993; 178:2193-200.
34. Lien E, Means TK, Heine H et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105:497-504.
35. Gerard C. For whom the bell tolls. Nature 1998; 395:217-9.
36. Yang RB, Mark MR, Gray A et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 1998; 395:284-8.
37. Chow JC, Young DW, Colenbock DT et al. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274:10689-92.
38. Baeuerle PA, Baichwal VR. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997; 65:111-35.
39. Garin EH, Blanchard DK, Matsushima K et al. IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kid Int 1994; 45:1311-7.
40. Bustos C, González E, Muley R et al. Increase of tumour necrosis factor α synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994; 24:799-805.
41. Suranyi MC, Guasch A, Hall BM et al. Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kidney Dis 1993; 121:251-9.
42. Daniel V, Trautmann Y, Konrad M et al. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 1997; 47:289-97.
43. Essner R, Rhoades K, Mcbride WH et al. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989; 142:3857-61.
44. Gautam S, Tebo JM, Hamilton TA. IL-4 suppresses cytokine gene expression induced by IFN-γ and/or IL-2 in murine peritoneal macrophages. J Immunol 1992; 148:1725-30.
45. Mijatovic T, Kruys V, Caput D et al. Interleukin-4 and -13 inhibit tumor necrosis factor-α mRNA translatioal activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997; 272:14394-8.